232 related articles for article (PubMed ID: 34680065)
21. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
22. Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases.
Huber J; Longaker MT; Quarto N
Front Endocrinol (Lausanne); 2023; 14():1168898. PubMed ID: 37293498
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
Link A; Kupcinskas J
World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
[TBL] [Abstract][Full Text] [Related]
26. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection.
Sehovic E; Urru S; Chiorino G; Doebler P
BMC Cancer; 2022 Jun; 22(1):634. PubMed ID: 35681127
[TBL] [Abstract][Full Text] [Related]
28. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
30. The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).
Yang G; Wu Y; Wan R; Sang H; Liu H; Huang W
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34296296
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis.
Liu H; Li P; Chen L; Jian C; Li Z; Yu A
Onco Targets Ther; 2017; 10():5229-5236. PubMed ID: 29138575
[TBL] [Abstract][Full Text] [Related]
32. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
[TBL] [Abstract][Full Text] [Related]
34. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs as biomarkers for diagnosis and prediction of preeclampsia: A systematic review and meta-analysis.
Yin Y; Liu M; Yu H; Zhang J; Zhou R
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():121-132. PubMed ID: 32871438
[TBL] [Abstract][Full Text] [Related]
36. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer.
Müller S; Janke F; Dietz S; Sültmann H
Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Guo HB; Zhang H; Bu J; Xiao T
Oncol Lett; 2015 Sep; 10(3):1662-1668. PubMed ID: 26622728
[TBL] [Abstract][Full Text] [Related]
38. The Value of Circulating microRNAs for Diagnosis and Prediction of Preeclampsia: a Meta-analysis and Systematic Review.
Qin S; Sun N; Xu L; Xu Y; Tang Q; Tan L; Chen A; Zhang L; Liu S
Reprod Sci; 2022 Nov; 29(11):3078-3090. PubMed ID: 34817849
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
40. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
